Prognostic Implications of the High-Sensitive C-Reactive Protein in the Catheter Ablation of Atrial Fibrillation

American Journal of Cardiology

Volumn 105, Issue 4, 2010, Pages 495-501

  Lin, Yenn Jiang ^a,b   Tsao, Hsuan Ming ^b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Tuan, Ta Chuan ^a   Hu, Yu Feng ^a   Udyavar, Ameya R ^a   Tsai, Wen Chin ^c   Chang, Chien Jung ^a   Tai, Ching Tai ^a   Lee, Pi Chang ^a   Suenari, Kazuyoshi ^a   Huang, Shih Yu ^a   Tung, Nguyen Huu ^a   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; C REACTIVE PROTEIN; FLECAINIDE; PROPAFENONE;

ADULT; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECTOPIC TISSUE; ELECTRIC POTENTIAL; ENZYME SPECIFICITY; FEMALE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VEIN; RECURRENT DISEASE; RESTRICTION MAPPING; TREATMENT OUTCOME;

ADULT; AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CATHETER ABLATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 75349102512     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.019     Document Type: Article

References (26)

1. Calkins H., Brugada J., Packer D.L., Cappato R., Chen S.A., Crijns H.J., Damiano Jr. R.J., Davies D.W., Haines D.E., Haissaguerre M., Iesaka Y., Jackman W., Jais P., Kottkamp H., Kuck K.H., Lindsay B.D., Marchlinski F.E., McCarthy P.M., Mont J.L., Morady F., Nademanee K., Natale A., Pappone C., Prystowsky E., Raviele A., Ruskin J.N., and Shemin R.J. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4 (2007) 816-861
2. Chen S.A., Hsieh M.H., Tai C.T., Tsai C.F., Prakash V.S., Yu W.C., Hsu T.L., Ding Y.A., and Chang M.S. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100 (1999) 1879-1886
3. Nademanee K., McKenzie J., Kosar E., Schwab M., Sunsaneewitayakul B., Vasavakul T., Khunnawat C., and Ngarmukos T. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43 (2004) 2044-2053
4. O'Neill M.D., Jais P., Takahashi Y., Jonsson A., Sacher F., Hocini M., Sanders P., Rostock T., Rotter M., Pernat A., Clementy J., and Haissaguerre M. The stepwise ablation approach for chronic atrial fibrillation-evidence for a cumulative effect. J Interv Card Electrophysiol 16 (2006) 153-167
5. Issac T.T., Dokainish H., and Lakkis N.M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 50 (2007) 2021-2028
6. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., and Van Wagoner D.R. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
7. Anderson J.L., len Maycock C.A., Lappe D.L., Crandall B.G., Horne B.D., Bair T.L., Morris S.R., Li Q., and Muhlestein J.B. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 94 (2004) 1255-1259
8. Watanabe E., Arakawa T., Uchiyama T., Kodama I., and Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 108 (2006) 346-353
9. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148 (2004) 462-466
10. Lin Y.J., Kao T., Tai C.T., Chang S.L., Lo L.W., Tuan T.C., Udyavar A.R., Hu Y.F., Tso H.W., Higa S., and Chen S.A. Spectral analysis during sinus rhythm predicts an abnormal atrial substrate in patients with paroxysmal atrial fibrillation. Heart Rhythm 5 (2008) 968-974
11. Chang S.L., Lin Y.J., Tai C.T., Lo L.W., Tuan T.C., Udyavar A.R., Hu Y.F., Chiang S.J., Wongcharoen W., Tsao H.M., Ueng K.C., Higa S., Lee P.C., and Chen S.A. Induced atrial tachycardia after circumferential pulmonary vein isolation of paroxysmal atrial fibrillation: electrophysiological characteristics and impact of catheter ablation on the follow-up results. J Cardiovasc Electrophysiol 20 (2009) 388-394
12. Lo L.W., Tai C.T., Lin Y.J., Chang S.L., Wongcharoen W., Hsieh M.H., Tuan T.C., Udyavar A.R., Hu Y.F., Chen Y.J., Chiang S.J., Tsao H.M., and Chen S.A. Characteristics and outcome in patients receiving multiple (more than two) catheter ablation procedures for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 19 (2008) 150-156
13. Lin W.S., Tai C.T., Hsieh M.H., Tsai C.F., Lin Y.K., Tsao H.M., Huang J.L., Yu W.C., Yang S.P., Ding Y.A., Chang M.S., and Chen S.A. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 107 (2003) 3176-3183
14. Udyavar A.R., Huang S.H., Chang S.L., Lin Y.J., Tai C.T., Lo L.W., Tuan T.C., Hu Y.F., Wongcharoen W., Tsao H.M., Higa S., and Chen S.A. Acute effect of circumferential pulmonary vein isolation on left atrial substrate. J Cardiovasc Electrophysiol 20 (2009) 715-722
15. Chang S.L., Tai C.T., Lin Y.J., Wongcharoen W., Lo L.W., Tuan T.C., Udyavar A.R., Chang S.H., Tsao H.M., Hsieh M.H., Hu Y.F., Chen Y.J., and Chen S.A. The efficacy of inducibility and circumferential ablation with pulmonary vein isolation in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 18 (2007) 607-611
16. Lin Y.J., Tai C.T., Kao T., Chang S.L., Wongcharoen W., Lo L.W., Tuan T.C., Udyavar A.R., Chen Y.J., Higa S., Ueng K.C., and Chen S.A. Consistency of complex fractionated atrial electrograms during atrial fibrillation. Heart Rhythm 5 (2008) 406-412
17. Lin Y.J., Tai C.T., Chang S.L., Lo L.W., Tuan T.C., Wongcharoen W., Udyavar A.R., Hu Y.F., Chang C.J., Tsai W.C., Kao T., Higa S., and Chen S.A. Efficacy of additional ablation of complex fractionated atrial electrograms for catheter ablation of nonparoxysmal atrial fibrillation. J Cardiovasc Electrophysiol 20 (2009) 607-615
18. Kumagai K., Khrestian C., and Waldo A.L. Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. Circulation 95 (1997) 511-521
19. Verma A., Wazni O.M., Marrouche N.F., Martin D.O., Kilicaslan F., Minor S., Schweikert R.A., Saliba W., Cummings J., Burkhardt J.D., Bhargava M., Belden W.A., Abdul-Karim A., and Natale A. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 45 (2005) 285-292
20. Chang S.L., Tai C.T., Lin Y.J., Wongcharoen W., Lo L.W., Tuan T.C., Udyavar A.R., Chang S.H., Tsao H.M., Hsieh M.H., Hu Y.F., Chen Y.J., and Chen S.A. Biatrial substrate properties in patients with atrial fibrillation. J Cardiovasc Electrophysiol 18 (2007) 1134-1139
21. Marcus G.M., Smith L.M., Glidden D.V., Wilson E., McCabe J.M., Whiteman D., Tseng Z.H., Badhwar N., Lee B.K., Lee R.J., Scheinman M.M., and Olgin J.E. Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm 5 (2008) 215-221
22. Rotter M., Jais P., Vergnes M.C., Nurden P., Takahashi Y., Sanders P., Rostock T., Hocini M., Sacher F., and Haissaguerre M. Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol 47 (2006) 1231-1233
23. Nakamura Y., Nakamura K., Fukushima-Kusano K., Ohta K., Matsubara H., Hamuro T., Yutani C., and Ohe T. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res 111 (2003) 137-142
24. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
25. Boyden P.A., Tilley L.P., Albala A., Liu S.K., Fenoglio Jr. J.J., and Wit A.L. Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. Circulation 69 (1984) 1036-1047
26. Huang J.L., Tai C.T., Lin Y.J., Huang B.H., Lee K.T., Higa S., Yuniadi Y., Chen Y.J., Chang S.L., Lo L.W., Wongcharoen W., Ting C.T., and Chen S.A. Substrate mapping to detect abnormal atrial endocardium with slow conduction in patients with atypical right atrial flutter. J Am Coll Cardiol 48 (2006) 492-498